Polypharmacy and Healthy Aging in People Living with HIV Aged 75 and Older

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on people living with HIV who are 75 years or older and receive care at Nice University Hospital. It will collect quantitative data and gather insights from interviews with advanced practice nurses to understand polypharmacy and potentially inappropriate prescriptions. The goal is to identify care pathways that address complex needs and support healthy aging as defined by WHO guidelines. No experimental drug interventions are involved; the study uses observational data to inform future care optimization. Results may inform adjustments to clinical pathways to improve safety and quality of life for this high-risk group.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* HIV-positive
* Aged 75 or over
* Affiliated with the social security system
* Having expressed no objection to participating in the study

Exclusion Criteria:

* Refusal to participate
* Known severe cognitive impairment preventing the interview from being conducted
* Patient under guardianship or conservatorship

Where it's running

• CHU de NICE
  Nice, CHU de Nice, France Recruiting

Study contacts

• Study coordinator: Lysandre BLANCKEMAN
• Email: blanckerman.l@chu-nice.fr
• Phone: 04 92 03 54 67

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide

  This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.

  Recruiting Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida · Paris · NCT07921472

• Multiple interventions to try for HIV remission in people on ART

  This study tests a combination approach, including intensified ART, latency-reversal agents, and autologous dendritic cell therapy, to see if people living with HIV on long-term ART can achieve sustained viral suppression or prolonged remission.

  Recruiting Phase 2 Federal University of São Paulo · São Paulo, São Paulo · NCT07903441

• Portable chest X-ray screening to rapidly find TB in migrants

  A community-based TB screening effort using mobile chest X-rays and AI-assisted readings is tested among migrant adults in New York City to see if it helps identify active TB earlier and connect people to care.

  Recruiting Columbia University · New York, New York · NCT07737275

• Two-probe thermal ablation for cervical precancer in WLWH in South Africa

  This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in South Africa.

  Recruiting Fred Hutchinson Cancer Center · Durban · NCT07645378

• Two-probe thermal ablation for cervical precancer in WLWH in Zimbabwe

  This study tests whether using two TA probes (endocervical and ectocervical) is better than one probe for treating cervical precancer in women living with HIV in Zimbabwe.

  Recruiting Fred Hutchinson Cancer Center · Harare · NCT07645352

• TransAction program to improve HIV prevention and care for transgender women in Ho Chi Minh City

  This trial will test whether TransAction—individual risk-reduction sessions, skill-building and group support, plus social events—helps transgender women in Ho Chi Minh City move forward in HIV prevention and care compared with social events alone.

  Recruiting University of California, Los Angeles · Ho Chi Minh City · NCT07495059

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.